Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year

Tissue Plasminogen Activator Effects On Stroke And Physical Therapy Ou by Lindsey Leboeuf

Impact of Tissue Plasminogen Activator on the Neurovascular Unit: From Clinical Data to Experimental Evidence - Denis Vivien, Maxime Gauberti, Axel Montagne, Gilles Defer, Emmanuel Touzé, 2011

Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways - ScienceDirect

The Neurotoxicity of Tissue Plasminogen Activator? - Jaspreet Kaur, Zonghang Zhao, Gary M. Klein, Eng H. Lo, Alastair M. Buchan, 2004

Intravenous recombinant tissue plasminogen activator (IV rt-PA)

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial - The Lancet Neurology

Tissue Plasminogen Activator for Acute Ischemic Stroke (Alteplase, Activase®)

NeuroEMCrit - Time is Brain - Acute Ischemic Stroke Part I: Vascular Syndromes and Thrombolysis

Reperfusion therapy in acute ischemic stroke: dawn of a new era?, BMC Neurology

Safety of Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke. Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Trial, Part I

Surgical Neurology International

Full article: Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase

Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke – topic of research paper in Clinical medicine. Download scholarly article PDF and